Navigation Links
Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease
Date:6/15/2011

clinical development program that when completed will have enrolled more than 750 patients at over 100 medical centers throughout the U.S., Canada, South America, Western Europe and Russia.  Based on the specified clearance for the Russian Health Authority, with positive safety and efficacy data from this single registration study, Cardium's Russian sponsor and development partner, Advanced Biosciences Research, an affiliate of the contract research organization bioRASI, would be in a position to consider the submission of an application for marketing and sales of Generx in the Russian Federation, and to advance forward with applications and submissions seeking approval for marketing and sales of Generx in certain other countries of the Commonwealth of Independent States, comprising former republics under the Soviet Union.  The ASPIRE study could also provide additional clinical evidence regarding the safety and effectiveness of Generx that would be useful for optimizing and broadening commercial development pathways in other industrialized countries.

Positive results from the prior Phase 2a clinical study (Grines et al., J Am Coll Cardiol 2003; 42:1339-47) showed that Generx improved myocardial blood flow in the ischemic region of the hearts of men and women following a single intracoronary infusion as measured by the objective efficacy endpoint of SPECT imaging.  As noted in the publication, the mean change observed in Generx-treated patients was a 4.2% absolute reduction (which represents a 20% relative reduction) in the reversible perfusion defect size from baseline at eight weeks (p<0.001), while the placebo group showed only a 1.6% absolute reduction from baseline (not significant) at eight weeks following treatment.  The observed treatment effect for patients receiving Generx was similar in magnitude to that reported in the literature for patients undergoing angioplasty/stent or revascularization procedures with rev
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
4. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
5. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
6. Semafores SF1126 Exhibits Antitumor and Antiangiogenic Activity
7. Multiple Presentations Confirm Clinical Efficacy and High Rate of Patient Compliance Using Provent® Sleep Apnea Therapy to Treat Obstructive Sleep Apnea
8. Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®
9. Accuray Successfully Completes Acquisition of TomoTherapy
10. Vertex Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need
11. TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... of the "Research and Future Development Trend Forecast ... offering. At present, there are 35,600 dialysis ... concentration ratio are large due to the different regional ... dialysis centers in other Asian countries are operated by ...
(Date:5/27/2015)... 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced today that it will present at the ... 2015 at the Luxe Sunset Hotel in ... presentation by Michael Becker , Relmada,s senior vice ... begin at 2:00 p.m. PT/5:00 p.m. ET. A live ...
(Date:5/27/2015)... , May 27, 2015  Halozyme Therapeutics, Inc. ... (Ventana), a member of the Roche Group, announced today ... and for Ventana to ultimately commercialize, a companion diagnostic ... The Ventana assay will be used ... a glycosaminoglycan – a chain of natural sugars distributed throughout ...
Breaking Medicine Technology:China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 2Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 4Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 5
... SAN DIEGO , Jan. 20, 2010 Amylin Pharmaceuticals, ... for the fourth quarter and full year 2009 on Wednesday, January ... . Daniel M. Bradbury , Amylin,s president and chief executive officer, ... financial results for the fourth quarter and year ended December 31, ...
... 20 Roper Industries, Inc.   (NYSE: ... of 2009, ended December 31, 2009 , will be released before ... call to discuss these results has been scheduled for 8:30 AM ... be accessed via webcast or by dialing +1 888-539-3679 (US/ Canada ) ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Year-End Financial Results 2
(Date:5/27/2015)... 2015 CRN International, the radio marketing ... new Chief Financial Officer. , Prinner most recently was ... that held financial/operational executive positions at telecom and technology ... Communications, Utilicom, and SNET. His accounting and consulting ... CRN, Prinner will be able to tap into his ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Danish scientists ... line” biomarkers that have the potential to help in ... to read the full story that has just ... University in Aalborg, Denmark say new biomarkers found in ... outlook for patients with malignant mesothelioma . ...
(Date:5/27/2015)... Widely regarded as being Arizona’s ... adults ages 18 to 40, Scottsdale Recovery Center ... Joint Commission. The announcement follows SRC’s recent ... entailing a number of added clinical services, among ... treatment program in lieu of a growing national ...
(Date:5/27/2015)... MA (PRWEB) May 27, 2015 Join us ... . This family-friendly event seeks to spread awareness of brain ... promoting an overall appreciation for life. , The 3rd ... off from the Braham Area Community Center located at 655 ... Registration opens at 8:00am, while the 5K Walk/Run kicks off ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 This year, ... health awareness campaign and encouraging those affected to seek assistance ... Mental Health (NAMI), one in five children, ages 13 ... illness. Additionally, 50% of all cases of mental illness within ... suggesting, it is essential to seek help before reaching a ...
Breaking Medicine News(10 mins):Health News:CRN International Names New Chief Financial Officer 2Health News:New Report Highlights Current and Emerging Biomarkers for Mesothelioma, According to Surviving Mesothelioma 2Health News:Arizona Drug Treatment Center SRC Announces JCAHO Accreditation 2Health News:Renowned Brain Aneurysm Foundation to Benefit from 3rd Annual Appreciation for Life 5K Walk/Run in Braham, MN Being Held on June 6th 2Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3
... similar ailment experienced these subtle attacks, scientists say , , ... genetically altered to develop an Alzheimer,s-like illness undergo "silent" ... College of Medicine, the seizures may explain why some ... The seizures observed in the mice would not be ...
... Tenn., Sept. 5 NFL great Eddie George,believes there,s ... 40 to stay fit and,prevent disease -- and more ... to,undertake a six month experiment to see if he,s ... such stars as Donovan McNabb, Jerome Bettis,Reggie Wayne and ...
... 5 Your child has been,playing outside. His hands are ... a nightly ritual in millions of homes all over the ... washing isn,t just about dirt. The U.S. Centers for Disease,Control ... important,things children can do to help stay healthy. According ...
... Shipcom Wireless, Inc., a leading,global provider of ... mobility and RFID solutions, announced,today that it will ... second,generation Electronic Product Code (EPC Gen. 2) RFID ... Group,s Future Store Initiative. The Future Store ...
... Fitness Systems,based in Gaithersburg, Maryland, has been named ... which just released its,2007 Inc. 5000 ranking of ... be found on Inc. magazine,s website at ... Heartline achieved a 65.6% growth rate in ...
... Close Up TV News recognizes Dr.,David Cohen of ... and patient care. To view the Multimedia News ... and highly respected cardiologist for over 20 years,Dr. Cohen ... wide variety of new,catheter-based therapies for vascular diseases. Circulatory ...
Cached Medicine News:Health News:Alzheimer's Patients May Suffer 'Silent' Seizures 2Health News:Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle 2Health News:When Should Children Wash Their Hands? 2Health News:Shipcom Partners With DOKUMENTA for METRO's Future Store Initiative 2Health News:Shipcom Partners With DOKUMENTA for METRO's Future Store Initiative 3Health News:Heartline(R) Fitness Systems Named to Inc. Magazine's Inaugural List of the 5000 Fastest Growing Private Companies in U.S.... 2Health News:Video: Circulatory Care of New Jersey 2
The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
Diagnostic and laboratory test reference. Get help with test preparation, interpretation, follow-up, and reimbursement....
... HIPAA-compliant wireless technology that makes fully ... and personnel a reality. This advance ... or levels means a ... shorter hospital stays and improved outcomes. ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: